Last week, I had a fascinating one-on-one conversation with a whip-smart CEO of a biotech company. He gave me two ideas that might generate some big biotech recommendations in the coming months. I’ll give you the full details in this alert. But before we go any further, I want you to stop everything and sell one pick that just hasn’t worked out as planned…
↧